San Diego Reader February 23, 2017 23
We are conducting the following studies:
DIAGNOSED WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND HAVE A PERSISTENT RASH?
We are conducting a clinical research study testing the effectiveness of a new investigational medication for lupus and the associated rash.
Qualified Participants Must: • Be diagnosed with SLE with a moderate to severe, persistent rash. • Be willing to undergo physical examination and blood tests to determine eligibility for the study.
Qualified Participants Will Receive: • Comprehensive evaluation of current lupus disease activity. • Compensation up to $1,125 will be available for time and travel. • Study related medication, care and medical testing at no cost.
RA Hurts. Swelling. Joint pain. Stiffness.
Is the SELECT clinical research study right for you?
A local clinical study testing an investigational medication for rheumatoid arthritis (RA) is enrolling now.
You may qualify for the SELECT study if you:
•Are at least 18 years old •Have Rheumatoid Arthritis
•Do NOT have another inflammatory joint disease such as gout
Qualified volunteers may receive:
•No-cost investigational study medication for RA
•No-cost study-related care from a study doctor
•Compensation up to $XXX may be available for time and travel
All study-related care will be at no cost you, and you can continue seeing your primary care doctor during the study. Health insurance and doctor referrals are not required to participate.
Bothered by knee or hip OSTEOARTHRITIS PAIN?
A clinical research study for knee or hip pain caused by osteoarthritis is enrolling now.
• Investigational medication for up to 56 weeks
• Study-related care from a local doctor
To learn more, call: 619-452-3951
Reimbursement for study-related time and travel may be provided.
www.triwestresearch.com •
patients@triwestresearch.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
